Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12 (NDUFB4P12) is a pseudogene in the human genome and does not encode a functional protein.[1][3]** Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations, deletions, or truncations preventing protein expression. This pseudogene is related to the functional gene NDUFB4, which codes for a subunit of mitochondrial Complex I (NADH dehydrogenase), but NDUFB4P12 itself has no known biological function, clinical utility, or role in disease.[1][3][5] Additional clarifying notes: - This entry is *not* a valid therapeutic target as pseudogenes do not encode proteins that could be pharmacologically targeted. - There is no evidence this pseudogene acts as a non-coding RNA, regulatory sequence, or other functional element based on the available sources. Summary: NDUFB4P12, NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12, is a pseudogene with no protein product, no functional role, and no value as a therapeutic target, biomarker, or disease gene[1][3][5].
Not applicable (no protein product or known inhibitors/activators)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12 (NDUFB4P12).